Current Report · Items 8.01, 9.01 · 8-K
Frequency Electronics, Inc.
FEIMNASDAQEQUITYCurrent
Other Events
Item 8.01. Other Events. As previously disclosed, on July 30, 2026, Frequency Electronics, Inc. (the “Company”) completed an offering (the “Offering”) of 1,739,131 shares of the Company’s common stock, par value $1.00 per share (“Common Stock”), pursuant to an underwriting agreement (the “Underwriting Agreement”) among the Company, Edenbrook Value Fund, LP and Edenbrook Long Only Value Fund, LP, a…
Filed Aug 5, 2026Accepted Aug 5, 2026, 4:15 PM EDTCIK 39020Accession 0001185185-26-003285
Company context
Frequency Electronics, Inc. (FEI) is a world leader in precision time and frequency generation technology, which is incorporated into commercial and U.S. Government satellites, Command, Control, Communication, Computer, Intelligence, Surveillance and Reconnaissance (“C4ISR”), and Electronic Warfare (“EW”) systems. Its technology is used for a wide range of space and non-space applications. FEI has received over 100 awards of excellence for achievements in providing high performance electronic assemblies for over 150 space and DOW programs. The Company invests significant resources in research and development to expand its capabilities and markets.
Current securities
Disclosure sections
Items 8.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
As previously disclosed, on July 30, 2026, Frequency Electronics, Inc.
(the “Company”) completed an offering (the “Offering”) of 1,739,131 shares of the Company’s common stock,
par value $1.00 per share (“Common Stock”), pursuant to an underwriting agreement (the “Underwriting Agreement”)
among the Company, Edenbrook Value Fund, LP and Edenbrook Long Only Value Fund, LP, as selling stockholders (the “Selling Stockholders”),
and Morgan Stanley & Co. LLC, as representative of the several underwriters named in Schedule II thereto (the “Underwriters”).
The Company offered and sold 1,086,957 shares of Common Stock and the Selling Stockholders offered and sold a total of 652,174 shares
of Common Stock. In addition, the Company granted the Underwriters an option, exercisable for 30 days following the date of the Underwriting
Agreement, to purchase up to 260,869 additional shares of Common Stock from the Company (the “Option Shares”).
On August 3, 2026, the Underwriters exercised their option in full
and on August 5, 2026, the Underwriters purchased the Option Shares. The gross proceeds to the Company from the sale of the Option Shares,
before deducting the underwriting discounts and commissions and offering expenses, were approximately $14.1 million.
The Company intends to use the net proceeds from the purchase of the
Option Shares to fund additional growth opportunities, including for capital expenditures, working capital and other general corporate
purposes.
The legal opinion and consent of McGuireWoods LLP relating to the validity
of the Option Shares is filed herewith as Exhibit 5.1.
The Option Shares have
been registered under the Securities Act of 1933, as amended, pursuant to a registration statement on Form S-3 (File No. 333-297549) (the
“Registration Statement”). The Company has filed with the U.S. Securities and Exchange Commission a preliminary prospectus
supplement dated July 28, 2026 and a final prospectus supplement, dated July 28, 2026, together with an accompanying prospectus dated
July 21, 2026, relating to the offer and sale of the Option Shares.